Mixed Reality and Virtual Reality Technology With Mirror Therapy for Stroke Rehabilitation

Launched by CHANG GUNG MEMORIAL HOSPITAL · Jun 6, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring new ways to help people recover from strokes using exciting technology like Virtual Reality (VR) and Mixed Reality (MR) combined with a treatment called Mirror Therapy (MT). The goal is to see if these new methods can help improve movement and function in the arms of stroke patients, compared to traditional therapy methods. Researchers will create and test these VR and MR systems, gather feedback from users about their experiences, and learn which patients might benefit the most based on their initial motor skills and mental visualization abilities.

To participate in this study, you need to be between 20 and 80 years old and have had a stroke affecting one side of your body at least six months ago. You should also be able to follow instructions and communicate your thoughts about the experience. However, individuals with certain conditions like severe speech difficulties or other serious health issues that affect movement or perception will not be eligible. If you join the trial, you can expect to use innovative technology in your rehabilitation and contribute to important research that may help others in the future.

Gender

ALL

Eligibility criteria

• • Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems \& Feasibility Study
• Inclusion Criteria:
• • diagnosed with unilateral stroke
• • age of 20 to 80 years
• • a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60
• • able to follow the study instructions and provide the feedback of user experiences verbally
• Exclusion Criteria:
• • diagnosed with global or receptive aphasia
• • the presence of severe neglect
• • the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception
• • Phase Ⅱ: Validation and Comparison of Clinical Treatment Efficacy
• Inclusion Criteria:
• • diagnosed with unilateral stroke
• • more than 6 months after stroke onset
• • age of 20 to 80 years
• • a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60
• • able to follow the study instructions
• • capable of participating in the assessment process and treatment program
• Exclusion Criteria:
• • diagnosed with global or receptive aphasia
• • the presence of severe neglect
• • the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception